Predicting the Risk of Death from Mesothelioma

risk of death from mesothelioma

New research suggests that the risk of death from mesothelioma does not always hinge on disease type or overall health. Researchers in Brazil and at Mayo Clinic have identified some subtle mesothelioma risk factors that only pathologists can see. These factors go beyond the characteristics of the mesothelioma cells themselves. The study shows the environment around the tumor, the number and type of immune system cells at the tumor site, and even how many cells are in the tumor can all impact the risk of death from mesothelioma.  Understanding the Risk Factors for Mesothelioma Asbestos exposure causes most cases of mesothelioma. But not everyone who encounters asbestos gets cancer. Genes and certain lifestyle factors may influence whether an exposed person … Continue reading Predicting the Risk of Death from Mesothelioma »

PD-L1 Expression and Mesothelioma Prognosis

PD-L1 expression and mesothelioma prognosis

The largest study yet on PD-L1 expression and mesothelioma prognosis shows that patients with more of this protein in their cells have poorer odds of survival. Programmed death ligand 1 (PD-L1) helps cancer cells evade immune system attack.  Other studies have suggested a link between PD-L1 expression and mesothelioma prognosis. But the new meta-analysis performed by two Chinese researchers appears to confirm it with an even bigger data set.  Understanding Mesothelioma Prognosis Malignant mesothelioma is an uncommon cancer that typically carries a poor prognosis. Many people diagnosed with mesothelioma lose their lives to the illness within a year.  But there are also many exceptions. Some mesothelioma survivors live for decades after a mesothelioma diagnosis. Australian Paul Kraus is an example. … Continue reading PD-L1 Expression and Mesothelioma Prognosis »

Personalized Immunotherapy for Mesothelioma: New Research Sheds Lights

personalized immunotherapy for mesothelioma

New research conducted by a team of German and Austrian scientists could help make personalized immunotherapy for mesothelioma possible.  Mesothelioma is an incurable cancer caused by exposure to asbestos. Immunotherapy is one of the most promising treatment approaches.  But immunotherapy drugs like Keytruda do not work for all patients. Scientists do not know exactly why this is. The new study suggests that understanding biomarkers could lead to better outcomes through personalized immunotherapy for mesothelioma.  How Does Immunotherapy Work? Immunotherapy is a broad term that means using the patient’s own immune system to fight their cancer. There are many different types of immunotherapy. Some involve stimulating an immune response. Others involve turning off the mechanism that lets mesothelioma cells hide from … Continue reading Personalized Immunotherapy for Mesothelioma: New Research Sheds Lights »

Genetics Affect Accuracy of SMRP Test for Mesothelioma

SMRP test for mesothelioma

The SMRP test for mesothelioma is a tool doctors use to help diagnose asbestos cancer and plan treatment. But new research suggests that the test is not as useful as it could be due to genetic variability.  Slovenian doctors say a person’s genetics influence how much SMRP they produce.  Based on their research, they recommend combining the SMRP test for mesothelioma with genetic testing. Their findings suggest the combination method produces a more accurate and useful mesothelioma biomarker. What is the SMRP Test for Mesothelioma? SMRP stands for soluble mesothelin-related peptides. They are produced when proteins found in the mesothelial membranes start to break down. Malignant mesothelioma is one condition that can trigger this breakdown.  As a mesothelioma tumor grows … Continue reading Genetics Affect Accuracy of SMRP Test for Mesothelioma »

The Importance of Subtype in PET Scanning for Mesothelioma Prognosis

PET scanning for mesothelioma

A new study of PET scanning for mesothelioma prognosis shows how much radioactive tracer a tumor absorbs can predict survival. This is especially true in people with the epithelioid mesothelioma subtype.  The study comes from the Sungkyunkwan University School of Medicine in Seoul, South Korea. Researchers studied the medical records of dozens of mesothelioma patients diagnosed between 2009 and 2018. They found that SUVmax, a key factor in PET scanning for mesothelioma, is directly related to mesothelioma survival.  How PET Scanning Works Mesothelioma diagnosis is challenging. Pleural mesothelioma grows quickly on the membrane around the lungs. It is one of the rarest and deadliest cancers. Positron emission tomography (PET) combined with computed tomography (CT) can help with diagnosis.  During a … Continue reading The Importance of Subtype in PET Scanning for Mesothelioma Prognosis »

Invasiveness of Peritoneal Mesothelioma: MRI Beats CT for Assessment

invasvieness of peritoneal mesothelioma

New research shows MRI beats CT when it comes to measuring the invasiveness of peritoneal mesothelioma. Scientists from several of the top US cancer centers ran the study. It included nearly 500 mesothelioma patients and appears in the journal Clinical Colorectal Cancer.  The study shows that the invasiveness of peritoneal mesothelioma is more visible on MRI than it is on CT. The news could make a difference in how doctors plan peritoneal mesothelioma treatment.  Peritoneal Cancer Index and Mesothelioma Peritoneal mesothelioma cancer grows on the peritoneal membrane lining the abdomen. Like all forms of mesothelioma, it usually comes from exposure to asbestos. Peritoneal mesothelioma accounts for about a fifth of all mesothelioma cases.  Doctors assess the invasiveness of peritoneal mesothelioma … Continue reading Invasiveness of Peritoneal Mesothelioma: MRI Beats CT for Assessment »

Mesothelioma Recurrence After PD Surgery

mesothelioma recurrence after PD surgery

A new study finds that mesothelioma recurrence after PD surgery is common but most patients still live for more than a year afterwards. More than a third were still alive three years after recurrence. The study included 90 Japanese patients with malignant pleural mesothelioma.  Those who lived for at least a year without mesothelioma recurrence after PD surgery had the best chance of longer term survival. A good performance status and undergoing additional treatment were also key to better outcomes.  Understanding Pleurectomy with Decortication (PD) Surgery Pleural mesothelioma is a virulent cancer that occurs on the membrane around the lungs. There is no cure for mesothelioma. Even with the best treatment, the cancer usually comes back. The goal of most … Continue reading Mesothelioma Recurrence After PD Surgery »

It May Be Possible to Predict Recurrence of Mesothelioma with Help from AI

predict recurrence of mesothelioma

A newly-published report suggests that artificial intelligence (AI) might help pathologists predict recurrence of mesothelioma. The report focuses on technology developed by the RIKEN Center for Advanced Intelligence Project (AIP) in Japan. The Center claims the computer program taught itself to recognize key features in images of cancer.  Some of the features were ones that even pathologists did not know about. The findings suggest that AI and pathologists could predict recurrence of mesothelioma better than pathologists alone.  How AI Might Predict Recurrence of Mesothelioma  A computer program usually has to be “taught” to perform a certain task. But this limits how far the learning can go. Instead of “teaching” it about cancer, researchers let the RIKEN technology learn on its … Continue reading It May Be Possible to Predict Recurrence of Mesothelioma with Help from AI »

Antibiotic May Boost Response to Radiation Therapy for Mesothelioma

response to radiation therapy

A common antibiotic may improve mesothelioma patients’ response to radiation therapy.  The concept is based on new research from the Perelman School of Medicine at the University of Pennsylvania.  Doctors there gave the antibiotic vancomycin to genetically modified mice. The mice had been modified to develop cancer. Mice that got the antibiotic had a better response to radiation therapy than untreated mice.  The effect applied not only to the treated tumor but also to tumors outside the treatment area. A heightened response to radiation therapy could be good news for patients with metastatic mesothelioma.  Understanding Cancer Response to Radiation Therapy Radiation therapy combats malignant mesothelioma by disrupting the DNA inside cancer cells. Mesothelioma tumors are irregularly-shaped which can make them … Continue reading Antibiotic May Boost Response to Radiation Therapy for Mesothelioma »

Is There a Risk for Depression Among Pleural Mesothelioma Patients?

risk for depression

Newly diagnosed pleural mesothelioma patients may be at higher risk for depression and that could be impacting their outcomes.   A new report finds that people diagnosed with advanced lung cancers are more likely to suffer from depression. Pleural mesothelioma is a form of lung cancer.  This risk for depression appears to have an impact on patients’ quality of life, their pain, and even the number of complications they experience.  Assessing the Risk for Depression in Cancer Patients Researchers at Ohio State University directed the study. It included 186 patients with Stage IV non-small-cell lung cancer. The patients had not yet started their cancer treatment.  Although pleural mesothelioma is not the same as non-small cell lung cancer, the two diseases share … Continue reading Is There a Risk for Depression Among Pleural Mesothelioma Patients? »

Get your free copy of
“Surviving Mesothelioma” Today!